Literature DB >> 16236024

Spectroscopic analyses of the binding kinetics of 15d-PGJ2 to the PPARgamma ligand-binding domain by multi-wavelength global fitting.

Takuma Shiraki1, Takashi S Kodama, Sayaka Shiki, Tatsuo Nakagawa, Hisato Jingami.   

Abstract

PPARgamma (peroxisome proliferator-activated receptor gamma) is a nuclear receptor that is activated by natural lipid metabolites, including 15d-PGJ2 (15-deoxy-Delta(12,14)-prostaglandin J2). We previously reported that several oxidized lipid metabolites covalently bind to PPARgamma through a Michael-addition to activate transcription. To separate the ligand-entering (dock) and covalent-binding (lock) steps in PPARgamma activation, we investigated the binding kinetics of 15d-PGJ2 to the PPARgamma LBD (ligand-binding domain) by stopped-flow spectroscopy. We analysed the spectral changes of 15d-PGJ2 by multi-wavelength global fitting based on a two-step chemical reaction model, in which an intermediate state represents the 15d-PGJ2-PPARgamma complex without covalent binding. The extracted spectrum of the intermediate state in wild-type PPARgamma was quite similar to the observed spectrum of 15d-PGJ2 in the C285S mutant, which cannot be activated by 15d-PGJ2, indicating that the complex remains in the inactive, intermediate state in the mutant. Thus 'lock' rather than 'dock' is one of the critical steps in PPARgamma activation by 15d-PGJ2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16236024      PMCID: PMC1360728          DOI: 10.1042/BJ20050930

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  The coregulator exchange in transcriptional functions of nuclear receptors.

Authors:  C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

2.  Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.

Authors:  H Eric Xu; Thomas B Stanley; Valerie G Montana; Millard H Lambert; Barry G Shearer; Jeffery E Cobb; David D McKee; Cristin M Galardi; Kelli D Plunket; Robert T Nolte; Derek J Parks; John T Moore; Steven A Kliewer; Timothy M Willson; Julie B Stimmel
Journal:  Nature       Date:  2002-02-14       Impact factor: 49.962

3.  Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

Authors:  H E Xu; M H Lambert; V G Montana; K D Plunket; L B Moore; J L Collins; J A Oplinger; S A Kliewer; R T Gampe; D D McKee; J T Moore; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 4.  Peroxisome proliferator-activated receptor gamma and metabolic disease.

Authors:  T M Willson; M H Lambert; S A Kliewer
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.

Authors:  R T Gampe; V G Montana; M H Lambert; A B Miller; R K Bledsoe; M V Milburn; S A Kliewer; T M Willson; H E Xu
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

6.  Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

Authors:  Lisa M Leesnitzer; Derek J Parks; Randy K Bledsoe; Jeff E Cobb; Jon L Collins; Thomas G Consler; Roderick G Davis; Emily A Hull-Ryde; James M Lenhard; Lisa Patel; Kelli D Plunket; Jennifer L Shenk; Julie B Stimmel; Christina Therapontos; Timothy M Willson; Steven G Blanchard
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

7.  Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.

Authors:  P Cronet; J F Petersen; R Folmer; N Blomberg; K Sjöblom; U Karlsson; E L Lindstedt; K Bamberg
Journal:  Structure       Date:  2001-08       Impact factor: 5.006

8.  T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.

Authors:  Gary Lee; Fabienne Elwood; John McNally; Jennifer Weiszmann; Michelle Lindstrom; Kate Amaral; Motonao Nakamura; Shichang Miao; Ping Cao; R Marc Learned; Jin-Long Chen; Yang Li
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

9.  Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma.

Authors:  Takuma Shiraki; Narutoshi Kamiya; Sayaka Shiki; Takashi S Kodama; Akira Kakizuka; Hisato Jingami
Journal:  J Biol Chem       Date:  2005-02-04       Impact factor: 5.157

10.  Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.

Authors:  Thomas M McIntyre; Aaron V Pontsler; Adriana R Silva; Andy St Hilaire; Yong Xu; Jerald C Hinshaw; Guy A Zimmerman; Kotaro Hama; Junken Aoki; Hiroyuki Arai; Glenn D Prestwich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

View more
  6 in total

1.  Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish.

Authors:  Tadayuki Tsujita; Li Li; Hitomi Nakajima; Noriko Iwamoto; Yaeko Nakajima-Takagi; Ken Ohashi; Koichi Kawakami; Yoshito Kumagai; Bruce A Freeman; Masayuki Yamamoto; Makoto Kobayashi
Journal:  Genes Cells       Date:  2010-12-09       Impact factor: 1.891

2.  Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes.

Authors:  Arion Kennedy; Soonkyu Chung; Kathleen LaPoint; Oluwatoyin Fabiyi; Michael K McIntosh
Journal:  J Nutr       Date:  2008-03       Impact factor: 4.798

3.  Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

Authors:  Francisco J Schopfer; Marsha P Cole; Alison L Groeger; Chen-Shan Chen; Nicholas K H Khoo; Steven R Woodcock; Franca Golin-Bisello; U Nkiru Motanya; Yong Li; Jifeng Zhang; Minerva T Garcia-Barrio; Tanja K Rudolph; Volker Rudolph; Gustavo Bonacci; Paul R S Baker; H Eric Xu; Carlos I Batthyany; Y Eugene Chen; Tina M Hallis; Bruce A Freeman
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 4.  Transduction of redox signaling by electrophile-protein reactions.

Authors:  Tanja K Rudolph; Bruce A Freeman
Journal:  Sci Signal       Date:  2009-09-29       Impact factor: 8.192

5.  Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception.

Authors:  Yingqi Weng; Patricia A Batista-Schepman; Marie E Barabas; Eli Q Harris; Thomas B Dinsmore; Elena A Kossyreva; Audra M Foshage; Michelle H Wang; Matthew J Schwab; Victoria M Wang; Cheryl L Stucky; Gina M Story
Journal:  Mol Pain       Date:  2012-09-27       Impact factor: 3.395

6.  Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism.

Authors:  Guangrui Yang; Zhanjun Jia; Toshinori Aoyagi; Donald McClain; Richard M Mortensen; Tianxin Yang
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.